-
1دورية أكاديمية
المؤلفون: Van Akkooi A. C. J., Hauschild A., Long G. V., Mandala' M., Kicinski M., Govaerts A. -S., Klauck I., Ouali M., Lorigan P. C., Eggermont A. M. M.
المساهمون: Van Akkooi, A. C. J., Hauschild, A., Long, G. V., Mandala', M., Kicinski, M., Govaerts, A. -S., Klauck, I., Ouali, M., Lorigan, P. C., Eggermont, A. M. M.
مصطلحات موضوعية: binimetinib, BRAF inhibitor, clinical trial, encorafenib, MEK inhibitor, melanoma, stage IIB, stage IIC
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37665297; info:eu-repo/semantics/altIdentifier/wos/WOS:001057984800001; volume:19; issue:30; firstpage:2017; lastpage:2027; numberofpages:11; journal:FUTURE ONCOLOGY; https://hdl.handle.net/11391/1566836Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85174752310
-
2دورية أكاديمية
المؤلفون: Garbe C., Dummer R., Amaral T., Amaria R. N., Ascierto P. A., Burton E. M., Dreno B., Eggermont A. M. M., Hauschild A., Hoeller C., Kaufmann R., Lebbe C., Mandala' M., Menzies A. M., Moreno D., Michielin O., Nathan P., Patel S. P., Robert C., Schadendorf D., Lorigan P. C., Scolyer R. A., Tawbi H. A., van de Wiel B. A., Blank C., Long G. V.
المساهمون: Garbe, C., Dummer, R., Amaral, T., Amaria, R. N., Ascierto, P. A., Burton, E. M., Dreno, B., Eggermont, A. M. M., Hauschild, A., Hoeller, C., Kaufmann, R., Lebbe, C., Mandala', M., Menzies, A. M., Moreno, D., Michielin, O., Nathan, P., Patel, S. P., Robert, C., Schadendorf, D., Lorigan, P. C., Scolyer, R. A., Tawbi, H. A., van de Wiel, B. A., Blank, C., Long, G. V.
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37193799; info:eu-repo/semantics/altIdentifier/wos/WOS:000988452900001; volume:29; issue:6; firstpage:1310; lastpage:1312; numberofpages:3; journal:NATURE MEDICINE; https://hdl.handle.net/11391/1566843Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85159427261
-
3دورية أكاديمية
المؤلفون: Chapman, P B, Robert, C, Larkin, J, Haanen, J B, Ribas, A, Hogg, D, Hamid, O, Ascierto, P A, Testori, A, Lorigan, P C, Dummer, R, Sosman, J A, Flaherty, K T, Chang, I, Coleman, S, Caro, I, Hauschild, A, McArthur, G A
المصدر: Chapman, P B; Robert, C; Larkin, J; Haanen, J B; Ribas, A; Hogg, D; Hamid, O; Ascierto, P A; Testori, A; Lorigan, P C; Dummer, R; Sosman, J A; Flaherty, K T; Chang, I; Coleman, S; Caro, I; Hauschild, A; McArthur, G A (2017). Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study. Annals of Oncology, 28(10):2581-2587.
مصطلحات موضوعية: Dermatology Clinic, 610 Medicine & health, BRAF mutation, dacarbazine, melanoma, vemurafenib
وصف الملف: application/pdf
العلاقة: https://www.zora.uzh.ch/id/eprint/140506/1/716_Chapman_PB._et_al_Vemurafenib_in_patients_with_BRAFV600_mutation-positive_metastatic_melanoma_Annals_of_Oncology_2017.pdfTest; info:pmid/28961848; urn:issn:0923-7534
الإتاحة: https://doi.org/10.5167/uzh-14050610.1093/annonc/mdx339Test
https://www.zora.uzh.ch/id/eprint/140506Test/
https://www.zora.uzh.ch/id/eprint/140506/1/716_Chapman_PB._et_al_Vemurafenib_in_patients_with_BRAFV600_mutation-positive_metastatic_melanoma_Annals_of_Oncology_2017.pdfTest -
4دورية أكاديمية
المؤلفون: Eggermont A. M. M., Blank C. U., Mandala M., Long G. V., Atkinson V. G., Dalle S., Haydon A. M., Meshcheryakov A., Khattak A., Carlino M. S., Sandhu S., Larkin J., Puig S., Ascierto P. A., Rutkowski P., Schadendorf D., Koornstra R., Hernandez-Aya L., Di Giacomo A. M., van den Eertwegh A. J. M., Grob J. -J., Gutzmer R., Jamal R., Lorigan P. C., van Akkooi A. C. J., Krepler C., Ibrahim N., Marreaud S., Kicinski M., Suciu S., Robert C., Menzies A., Lesimple T., Maio M., Linette G., Brown M., Hersey P., Svane I. M., Mortier L., Schachter J., Barrow C., Kudchadkar R., Song X., Dutriaux C., Quaglino P., Meier F., Queirolo P., Stroyakovskiy D., Bastholt L., Guillot B., Garbe C., Ortiz Romero P. L., Grange F., Mohr P., Algazi A., Bechter O., Hernberg M., Arnault J. -P., Saiag P., Loquai C., Meiss F., Simon J. -C., Bar-Sela G., Chiarion Sileni V., Fitzharris B., McCrystal M., Parente P., Baurain J. -F., Combemale P., Lebbe C., Hauschild A., Yamazaki N., Dummer R., Milhem M., Dzienis M., Walker J., Geoffrois L., Leccia M. -T., Kretschmer L., Hendler D., Lotem M., Mackiewicz A., Sekulovic L., Dunwoodie E., Hoeller C., Machet L., Hassel J., Hospers G. A. P., Passos M. -J., Levin M., Fehr M., Corrie P., Waterston A., Hallmeyer S., Schmidt H., Descamps V., Lacour J. -P., Berking C., Kiecker F., Ferrucci P. F., Yokota K., Aarts M., Jameson M., Winge-Main A. K., Ferreira P., Kim K., McNeil C., Hofmann-Wellenhof R., Kerger J., Aubin F., Utikal J., Ferraresi V., Inozume T., Kiyohara Y., Groenewegen G., Kapiteijn H., Matkovic S., Boehncke W. -H., Casasola R., Crook T., Marshall E., Skytta T., Avril M. -F., Jouary T., Hein R., Terheyden P., Aoi J., Takenouchi T., Straume O., Martins C., Mukhametshina G., Nathan P.
المساهمون: Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A. M., Meshcheryakov, A., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., van den Eertwegh, A. J. M., Grob, J. -J., Gutzmer, R., Jamal, R., Lorigan, P. C., van Akkooi, A. C. J., Krepler, C., Ibrahim, N., Marreaud, S., Kicinski, M., Suciu, S., Robert, C., Menzies, A., Lesimple, T., Maio, M., Linette, G., Brown, M., Hersey, P., Svane, I. M., Mortier, L., Schachter, J., Barrow, C., Kudchadkar, R., Song, X., Dutriaux, C., Quaglino, P., Meier, F., Queirolo, P., Stroyakovskiy, D., Bastholt, L., Guillot, B., Garbe, C., Ortiz Romero, P. L., Grange, F., Mohr, P., Algazi, A., Bechter, O., Hernberg, M., Arnault, J. -P., Saiag, P., Loquai, C., Meiss, F., Simon, J. -C., Bar-Sela, G., Chiarion Sileni, V., Fitzharris, B., Mccrystal, M., Parente, P., Baurain, J. -F., Combemale, P., Lebbe, C., Hauschild, A., Yamazaki, N., Dummer, R., Milhem, M., Dzienis, M., Walker, J., Geoffrois, L., Leccia, M. -T., Kretschmer, L., Hendler, D., Lotem, M., Mackiewicz, A., Sekulovic, L., Dunwoodie, E., Hoeller, C., Machet, L., Hassel, J., Hospers, G. A. P., Passos, M. -J., Levin, M., Fehr, M., Corrie, P., Waterston, A., Hallmeyer, S., Schmidt, H., Descamps, V., Lacour, J. -P., Berking, C., Kiecker, F., Ferrucci, P. F.
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33857412; info:eu-repo/semantics/altIdentifier/wos/WOS:000686283200032; volume:22; issue:5; firstpage:643; lastpage:654; numberofpages:12; journal:THE LANCET ONCOLOGY; https://hdl.handle.net/11365/1233237Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105830174; https://www.sciencedirect.com/science/article/pii/S1470204521000656Test
الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00065-6
https://hdl.handle.net/11365/1233237Test
https://www.sciencedirect.com/science/article/pii/S1470204521000656Test -
5دورية أكاديمية
المؤلفون: Bottomley A., Coens C., Mierzynska J., Blank C. U., Mandalà M., Long G. V., Atkinson V. G., Dalle S., Haydon A. M., Meshcheryakov A., Khattak A., Carlino M. S., Sandhu S., Puig S., Ascierto P. A., Larkin J., Lorigan P. C., Rutkowski P., Schadendorf D., Koornstra R., Hernandez-Aya L., Di Giacomo A. M., van den Eertwegh A. J. M., Grob J. -J., Gutzmer R., Jamal R., van Akkooi A. C. J., Krepler C., Ibrahim N., Marreaud S., Kicinski M., Suciu S., Robert C., Eggermont A. M. M., EORTC Melanoma Group, Lesimple T., Maio M., Linette G., Mortier L., Svane I. M., Schachter J., Brown M., Hersey P., Barrow C., Kudchadkar R., Dutriaux C., Song X., Quaglino P., Queirolo P., Meier F., Stroyakovskiy D., Guillot B., Romero P. L. O., Bastholt L., Garbe C., Grange F., Mohr P., Algazi A., Bechter O., Hernberg M., Loquai C., Meiss F., Chiarion Sileni V., Bar-Sela G., Fitzharris B., Saiag P., Arnault J. -P., Simon J. -C., Stephens R., Baurain J. -F., Lebbe C., Combemale P., Dummer R., Hauschild A., Parente P., Yamazaki N., Milhem M., Leccia M. -T., Geoffrois L., Kretschmer L., Dunwoodie E., Walker J., Lotem M., Hendler D., Mackiewicz A., Sekulovic L., Dzienis M., Hospers G. A. P., Siano M., Hassel J., Corrie P., Passos M. -J., Levin M., Hoeller C., Machet L., Hallmeyer S., Waterston A., Descamps V., Kiecker F., Aarts M., Schmidt H., Raimundo A., Nyakas M., Lacour J. -P., Berking C., Ferrucci P. F., Jameson M., Kim K., Yokota K., Kerger J., Aubin F., Groenewegen G., Kapiteijn H., Boehncke W. -H., Utikal J., Casasola R., Marshall E., Ferraresi V., Richtig E., Matkovic S., Inozume T., Crook T., McNeil C., Kiyohara Y., Avril M. -F., Hein R., Terheyden P., Nathan P., Aoi J., Skytta T., Jouary T., Takenouchi T., Straume O., Martins C., Mukhametshina G.
المساهمون: Bottomley, A., Coens, C., Mierzynska, J., Blank, C. U., Mandalà, M., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A. M., Meshcheryakov, A., Khattak, A., Carlino, M. S., Sandhu, S., Puig, S., Ascierto, P. A., Larkin, J., Lorigan, P. C., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., van den Eertwegh, A. J. M., Grob, J. -J., Gutzmer, R., Jamal, R., van Akkooi, A. C. J., Krepler, C., Ibrahim, N., Marreaud, S., Kicinski, M., Suciu, S., Robert, C., Eggermont, A. M. M., EORTC Melanoma, Group, Lesimple, T., Maio, M., Linette, G., Mortier, L., Svane, I. M., Schachter, J., Brown, M., Hersey, P., Barrow, C., Kudchadkar, R., Dutriaux, C., Song, X., Quaglino, P., Queirolo, P., Meier, F., Stroyakovskiy, D., Guillot, B., Romero, P. L. O., Bastholt, L., Garbe, C., Grange, F., Mohr, P., Algazi, A., Bechter, O., Hernberg, M., Loquai, C., Meiss, F., Chiarion Sileni, V., Bar-Sela, G., Fitzharris, B., Saiag, P., Arnault, J. -P., Simon, J. -C., Stephens, R., Baurain, J. -F., Lebbe, C., Combemale, P., Dummer, R., Hauschild, A., Parente, P., Yamazaki, N., Milhem, M., Leccia, M. -T., Geoffrois, L., Kretschmer, L., Dunwoodie, E., Walker, J., Lotem, M., Hendler, D., Mackiewicz, A., Sekulovic, L., Dzienis, M., Hospers, G. A. P., Siano, M., Hassel, J., Corrie, P., Passos, M. -J., Levin, M., Hoeller, C., Machet, L., Hallmeyer, S., Waterston, A., Descamps, V., Kiecker, F., Aarts, M.
مصطلحات موضوعية: Antibodies, Monoclonal, Humanized, Melanoma, Neoplasm Staging, Quality of Life, Skin Neoplasm, Double-Blind Method, Adult, Aged, Middle aged, Humans [MeSH]
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33857414; info:eu-repo/semantics/altIdentifier/wos/WOS:000708645000001; volume:22; issue:5; firstpage:655; lastpage:664; numberofpages:10; journal:THE LANCET ONCOLOGY; https://hdl.handle.net/11365/1233297Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105831665; https://www.sciencedirect.com/science/article/pii/S1470204521000814Test
الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00081-4
https://hdl.handle.net/11365/1233297Test
https://www.sciencedirect.com/science/article/pii/S1470204521000814Test -
6دورية أكاديمية
المؤلفون: Eggermont A. M. M., Blank C. U., Mandala M., Long G. V., Atkinson V. G., Dalle S., Haydon A. M., Meshcheryakov A., Khattak A., Carlino M. S., Sandhu S., Larkin J., Puig S., Ascierto P. A., Rutkowski P., Schadendorf D., Koornstra R., Hernandez-Aya L., Di Giacomo A. M., van den Eertwegh A. J. M., Grob J. -J., Gutzmer R., Jamal R., Lorigan P. C., van Akkooi A. C. J., Krepler C., Ibrahim N., Marreaud S., Kicinski M., Suciu S., Robert C.
المساهمون: Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A. M., Meshcheryakov, A., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., van den Eertwegh, A. J. M., Grob, J. -J., Gutzmer, R., Jamal, R., Lorigan, P. C., van Akkooi, A. C. J., Krepler, C., Ibrahim, N., Marreaud, S., Kicinski, M., Suciu, S., Robert, C.
مصطلحات موضوعية: Stage at diagnosi, Risk of relapse, Adjuvant therapy, Staging system, Metastatic relapse, Hormonal therapy, Clinical trial, pembrolizumab
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33492998; info:eu-repo/semantics/altIdentifier/wos/WOS:000652533100012; volume:39; issue:8; firstpage:944; lastpage:946; numberofpages:3; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11365/1233340Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85102657696
-
7دورية أكاديمية
المؤلفون: Eggermont A. M. M., Kicinski M., Blank C. U., Mandala M., Long G. V., Atkinson V., Dalle S., Haydon A., Khattak A., Carlino M. S., Sandhu S., Larkin J., Puig S., Ascierto P. A., Rutkowski P., Schadendorf D., Koornstra R., Hernandez-Aya L., Di Giacomo A. M., Van Den Eertwegh A. J. M., Grob J. -J., Gutzmer R., Jamal R., Lorigan P. C., Krepler C., Ibrahim N., Marreaud S., Van Akkooi A., Robert C., Suciu S.
المساهمون: Eggermont, A. M. M., Kicinski, M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., Van Den Eertwegh, A. J. M., Grob, J. -J., Gutzmer, R., Jamal, R., Lorigan, P. C., Krepler, C., Ibrahim, N., Marreaud, S., Van Akkooi, A., Robert, C., Suciu, S.
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31895407; info:eu-repo/semantics/altIdentifier/wos/WOS:000526653200013; volume:6; issue:4; firstpage:519; lastpage:527; numberofpages:9; journal:JAMA ONCOLOGY; http://hdl.handle.net/11365/1119759Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85077580577
-
8دورية أكاديمية
المؤلفون: Salih, Z., Banyard, A., Tweedy, J., Galvani, E., Middlehurst, P., Mills, S., Weightman, J., Gupta, A., Lorigan, P. C., Zhou, C., Dhomen, N., Valpione, S., Marais, R.
المساهمون: Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
العلاقة: https://dx.doi.org/10.1016/j.ejca.2021.11.015Test; Salih Z, Banyard A, Tweedy J, Galvani E, Middlehurst P, Mills S, et al. T cell immune awakening in response to immunotherapy is age-dependent. Eur J Cancer. 2021;162:11-21.; http://hdl.handle.net/10541/625002Test; Eur J Cancer
-
9
المؤلفون: Bottomley, A., Coens, C., Mierzynska, J., Blank, C. U., Mandalà, M., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A. M., Meshcheryakov, A., Khattak, A., Carlino, M. S., Sandhu, S., Puig, S., Ascierto, P. A., Larkin, J., Lorigan, P. C., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., van den Eertwegh, A. J. M., Grob, J. -J., Gutzmer, R., Jamal, R., van Akkooi, A. C. J., Krepler, C., Ibrahim, N., Marreaud, S., Kicinski, M., Suciu, S., Robert, C., Eggermont, A. M. M., EORTC Melanoma Group, Lesimple, T., Maio, M., Linette, G., Mortier, L., Svane, I. M., Schachter, J., Brown, M., Hersey, P., Barrow, C., Kudchadkar, R., Dutriaux, C., Song, X., Quaglino, P., Queirolo, P., Meier, F., Stroyakovskiy, D., Guillot, B., Romero, P. L. O., Bastholt, L., Garbe, C., Grange, F., Mohr, P., Algazi, A., Bechter, O., Hernberg, M., Loquai, C., Meiss, F., Chiarion Sileni, V., Bar-Sela, G., Fitzharris, B., Saiag, P., Arnault, J. -P., Simon, J. -C., Stephens, R., Baurain, J. -F., Lebbe, C., Combemale, P., Dummer, R., Hauschild, A., Parente, P., Yamazaki, N., Milhem, M., Leccia, M. -T., Geoffrois, L., Kretschmer, L., Dunwoodie, E., Walker, J., Lotem, M., Hendler, D., Mackiewicz, A., Sekulovic, L., Dzienis, M., Hospers, G. A. P., Siano, M., Hassel, J., Corrie, P., Passos, M. -J., Levin, M., Hoeller, C., Machet, L., Hallmeyer, S., Waterston, A., Descamps, V., Kiecker, F., Aarts, M., Schmidt, H., Raimundo, A., Nyakas, M., Lacour, J. -P., Berking, C., Ferrucci, P. F., Jameson, M., Kim, K., Yokota, K., Kerger, J., Aubin, F., Groenewegen, G., Kapiteijn, H., Boehncke, W. -H., Utikal, J., Casasola, R., Marshall, E., Ferraresi, V., Richtig, E., Matkovic, S., Inozume, T., Crook, T., Mcneil, C., Kiyohara, Y., Avril, M. -F., Hein, R., Terheyden, P., Nathan, P., Aoi, J., Skytta, T., Jouary, T., Takenouchi, T., Straume, O., Martins, C., Mukhametshina, G.
المساهمون: Boehncke, Wolf-Henning, Internal medicine, CCA - Cancer Treatment and quality of life, European Organisation for Research and Treatment of Cancer [Bruxelles] (EORTC), European Cancer Organisation [Bruxelles] (ECCO), Ospedale 'Santa Maria della Misericordia' = University Hospital 'Santa Maria della Misericordia', The University of Sydney, Princess Alexandra Hospital, Brisbane, University of Queensland [Brisbane], Centre Léon Bérard [Lyon], Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Edith Cowan University (ECU), Universitat de Barcelona (UB), The Christie NHS Foundation Trust [Manchester, Royaume-Uni], Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), Radboud University Medical Center [Nijmegen], Washington University School of Medicine in St. Louis, Washington University in Saint Louis (WUSTL), University Hospital of Siena, Amsterdam UMC - Amsterdam University Medical Center, Hôpital de la Timone [CHU - APHM] (TIMONE), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hannover Medical School [Hannover] (MHH), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM), Merck & Co. Inc, AP-HP. Université Paris Saclay, Institut Gustave Roussy (IGR), University Medical Center [Utrecht], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM), Merck Sharp & Dohme., Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Lancet. Oncology, Vol. 22, No 5 (2021) pp. 655-664
EORTC Melanoma Group 2021, ' Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial ', The Lancet Oncology, vol. 22, no. 5, pp. 655-664 . https://doi.org/10.1016/S1470-2045Test(21)00081-4
Lancet Oncology, 22, 5, pp. 655-664
The Lancet Oncology, 22(5), 655-664. Lancet Publishing Group
Lancet Oncology, 22, 655-664
Lancet Oncology
Lancet Oncology, 2021, 22 (5), pp.655-664. ⟨10.1016/S1470-2045(21)00081-4⟩
The Lancet Oncology, 22(5), 655-664. ELSEVIER SCIENCE INCمصطلحات موضوعية: Male, Skin Neoplasms, Medizin, Skin Neoplasms / drug therapy, Pembrolizumab, law.invention, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], MESH: Aged, 80 and over, 0302 clinical medicine, Melanoma / pathology, Randomized controlled trial, law, Monoclonal, 80 and over, Clinical endpoint, MESH: Double-Blind Method, 030212 general & internal medicine, Humanized, Melanoma, MESH: Aged, ddc:616, Aged, 80 and over, education.field_of_study, MESH: Middle Aged, Antibodies, Monoclonal, Humanized, Neoplasm Staging, Quality of Life, Double-Blind Method, Adult, Aged, Middle aged, Humans [MeSH], Hazard ratio, MESH: Neoplasm Staging, Middle Aged, Oncology, 030220 oncology & carcinogenesis, Female, Humans, medicine.medical_specialty, Melanoma / psychology, Skin Neoplasms / psychology, MESH: Melanoma, Antibodies, Monoclonal, Humanized / therapeutic use, Population, [SDV.CAN]Life Sciences [q-bio]/Cancer, Placebo, Antibodies, Melanoma / mortality, 03 medical and health sciences, Internal medicine, medicine, Adjuvant therapy, education, Skin Neoplasms / pathology, MESH: Humans, Melanoma / drug therapy, business.industry, MESH: Skin Neoplasms, MESH: Quality of Life, MESH: Adult, Skin Neoplasms / mortality, MESH: Male, Clinical trial, MESH: Antibodies, Monoclonal, Humanized, business, MESH: Female
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80dc0ff7069bff303dade337b8effb2dTest
https://archive-ouverte.unige.ch/unige:159804Test -
10دورية أكاديمية
المؤلفون: Eggermont A. M. M., Blank C. U., Mandala M., Long G. V., Atkinson V. G., Dalle S., Haydon A., Lichinitser M., Khattak A., Carlino M. S., Sandhu S., Larkin J., Puig S., Ascierto P. A., Rutkowski P., Schadendorf D., Koornstra R., Hernandez-Aya L., Di Giacomo A. M., van den Eertwegh A. J., Grob J. -J., Gutzmer R., Jamal R., Lorigan P. C., Lupinacci R., Krepler C., Ibrahim N., Kicinski M., Marreaud S., van Akkooi A. C., Suciu S., Robert C.
المساهمون: Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A., Lichinitser, M., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., van den Eertwegh, A. J., Grob, J. -J., Gutzmer, R., Jamal, R., Lorigan, P. C., Lupinacci, R., Krepler, C., Ibrahim, N., Kicinski, M., Marreaud, S., van Akkooi, A. C., Suciu, S., Robert, C.
مصطلحات موضوعية: Adjuvant therapy, AJCC-7, AJCC-8, EORTC 1325/KN-054, Melanoma, Pembrolizumab, Phase III trial, Predictive factor, Prognostic factor, Adult, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Disease-Free Survival, Double-Blind Method, Female, Human, Male, Middle Aged, Neoplasm Staging, Prognosi, Skin Neoplasm, Treatment Outcome
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31200321; info:eu-repo/semantics/altIdentifier/wos/WOS:000473270800017; volume:116; firstpage:148; lastpage:157; numberofpages:10; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11365/1119637Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85067063279